MusclePharm Corporation (OTCQB:MSLP)
MSLP , one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, yesterday announced Bodybuilding.com selected MSLP as the Supplement Company of the Month for October.
Bodybuilding.com recognizes leading supplement companies with products and services that are making a positive impact on the industry and their consumers each month.
“MusclePharm’s ads are in all the magazines with some of the biggest names not only in bodybuilding, but the entire sports world. You see their logo on every MMA event and their products are amongst the most popular in the industry today,” commented Jeremy Deluca, Bodybuilding.com’s President. “Bodybuilding.com is recognizing MusclePharm for their accomplishments and their loyal customer base by featuring them as the Supplement Company of the Month.”
MSLP is currently ranked #14 on Bodybuilding.com’s best selling Company list out of 563 companies. MSLP continues to increase its dominate brand presence in the sports nutrition world with over 1,000 customer product reviews and an average rating of 9.2 out 10.0 on Bodybuilding.com.
To learn more about MSLP visit: http://www.musclepharm.com
Inhibitex, Inc. (Nasdaq: INHX), recently reported that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections.
In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo.
Inland Real Estate Corporation (NYSE:IRC) reported that it will release its third quarter financial and operational results on Wednesday, November 3, 2010, prior to 8:30 a.m. CT (9:30 a.m. ET), before trading opens on the New York Stock Exchange (NYSE).
InnerWorkings, Inc. (Nasdaq:INWK), a leading global provider of managed print and promotional solutions, will announce its third quarter financial results on Thursday, November 4, 2010.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (OTCQB:MSLP).